NursingNotes
  • login
  • signup
  • Latest News
  • Clinical Updates
  • Professional
  • Education
  • Opinion
No Result
View All Result
NursingNotes
No Result
View All Result

Home > News

Remdesivir given fast-track approval to treat Coronavirus

The drug will be provided to the NHS free of charge by the manufacturer during the trial period.


26 May 2020
Remdesivir

Shutterstock

Remdesivir will be used to treat those hospitalised with severe COVID-19 infections.

The Medicines and Healthcare products Regulatory Agency (MHRA) has today approved an anti-viral drug Remdesivir under the Early Access to Medicines Scheme (EAMS) as the first medicine to treat COVID-19.



The move will allow the use of remdesivir in the treatment of adults and adolescents hospitalised with severe COVID-19 infection who meet a specific clinical criteria.

EAMS was set up by the MHRA to give patients with life-threatening or seriously debilitating conditions access to medicines that are not yet licenced, but when there is a clear, unmet medical need.

The MHRA has delivered this scientific opinion after a rigorous evaluation of the benefit/risk balance of the medicine, based on the data available.

This opinion does not replace the normal licensing procedures for medicines but supports prescribers and patients to make a decision on whether to use the medicine before its licence is approved.


Remdesivir’s current use in the UK will be for patients in cases of high unmet medical need determined by a physician through the EAMS, where it will be provided to the NHS free of charge by Gilead throughout the EAMS period.

Several clinical trials to evaluate remdesivir and its possible effects on patients with COVID-19 have already been approved by the MHRA and are ongoing in the UK.

Dr June Raine, MHRA Chief Executive, said: “We are committed to ensuring that patients can have fast access to promising new treatments for COVID-19.

“We will continue to work closely with the Department of Health and Social Care and other healthcare partners on protecting public health in the UK by prioritising our essential work on clinical trials, access to medicines, and the development of vaccines.”




Popular

Close-up of rapid Covid-19 home lateral flow antigen test with positive result

Special paid leave for Covid sickness and isolation scrapped for NHS workers

1 July 2022

student nurse staff nurse

Student nurses ‘used and abused’ on placements

13 June 2022

Patient lying on bed while nurse writing on clipboard in hospital

Nurses told to stop ‘overworking’ by staying late without pay

27 June 2022

Insight

Busy A&E waiting room

‘The NHS is having its worst winter ever – and the reasons run much deeper than COVID’

28 January 2022

Hospital curtain intensive care

‘During the Downing Street Christmas Party we were caring for dying patients and forbidden from seeing family’

8 December 2021

Vaccine inPPE

‘Making vaccination compulsory for NHS frontline workers likely to make patients suffer’

19 November 2021


Related Posts

Close-up the positive young nurse who is dialing medicine into the syringe indoors
Clinical

Hospitals reintroduce compulsory mask wearing for staff and patients

29 June 2022
London, England, UK, January 22nd 2022, Long covid symptoms sign on pharmacy shop window UK
Clinical

Tribunal rules long-Covid is a disability

21 June 2022
Nurse putting PPE in bin
News

Nurses may not have died if the Government purchased ‘decent’ PPE

15 June 2022
NursingNotes

© 2019 NursingNotes.co.uk

Navigate Site

  • Who are we?
  • Terms of Service
  • Privacy Policy
  • Contact Us
  • Agenda for Change Pay Scales

Follow Us

No Result
View All Result
  • Latest News
  • Clinical
  • Education
  • Health Politics
  • Opinion
  • Resources

© 2019 NursingNotes.co.uk